Literature DB >> 12113601

Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.

Pierina De Muro1, Pietro Fresu, Marilena Formato, Giancarlo Tonolo, Marco Mameli, Mario Maioli, Giovanni Maria Sanna, Gian Mario Cherchi.   

Abstract

BACKGROUND: Diabetic nephropathy may be related to an abnormal metabolism of glycosaminoglycans (GAG) in the glomerular basement membrane (GBM). The first manifestation of nephropathy is microalbuminuria, whose appearance indicates a loss of GBM selectivity. The present study evaluated whether GAG excretion becomes abnormal in parallel with microalbuminuria, and whether such abnormalities are also present in normoalbuminuric diabetic patients.
METHODS: We measured urinary GAG excretion in 60 patients with type 1 (insulin-dependent) diabetes mellitus and in 22 healthy subjects. GAG were isolated from 24-h urine using ion-exchange chromatography on DEAE Sephacel. GAG composition was determined by cellulose acetate electrophoresis and expressed as percentages by densitometric scanning of Alcian Blue stained strips.
RESULTS: On subgrouping for albuminuric status and glyco-metabolic control, we found high urinary GAG concentrations in all except the normoalbuminuric patients with good glyco-metabolic control. The urinary GAG electrophoretic pattern showed alterations in chondroitin sulphate (CS) and heparan sulphate (HS) relative contents. A higher frequency of low sulphated chondroitin sulphate-proteoglycan (LSC-PG) was observed in all patients, including those with normoalbuminuria and good glyco-metabolic control.
CONCLUSIONS: This urinary pattern may be indicative of an abnormal GBM metabolism. Since GAG play an important role in GBM permeability, these anomalies might consequently represent a first step towards selective changes of GBM in type 1 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113601

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus.

Authors:  D P K Ng; A Salim; Y Liu; L Zou; F G Xu; S Huang; H Leong; C N Ong
Journal:  Diabetologia       Date:  2011-10-25       Impact factor: 10.122

Review 2.  Advances in glycosaminoglycan detection.

Authors:  Shaukat A Khan; Robert W Mason; Hironori Kobayashi; Seiji Yamaguchi; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2020-03-27       Impact factor: 4.797

3.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

4.  Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Pierina De Muro; Antonio Junior Lepedda; Gabriele Nieddu; Michela Idini; Hai Quy Tram Nguyen; Omar Lobina; Pietro Fresu; Marilena Formato
Journal:  Biochem Res Int       Date:  2016-01-24

5.  Distinct osmoregulatory responses to sodium loading in patients with altered glycosaminoglycan structure: a randomized cross-over trial.

Authors:  Eliane F E Wenstedt; Jetta J Oppelaar; Stijn Besseling; Nienke M G Rorije; Rik H G Olde Engberink; Arie Oosterhof; Toin H van Kuppevelt; Bert-Jan H van den Born; Jan Aten; Liffert Vogt
Journal:  J Transl Med       Date:  2021-01-20       Impact factor: 5.531

6.  Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes.

Authors:  Antonio Junior Lepedda; Gabriele Nieddu; Silvia Rocchiccioli; Nadia Ucciferri; Michela Idini; Pierina De Muro; Marilena Formato
Journal:  J Diabetes Res       Date:  2018-02-06       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.